Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Income from Continuing Operations (2022 - 2025)

Praxis Precision Medicines has reported Income from Continuing Operations over the past 4 years, most recently at 97044000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 97044000.0 for Q4 2025, down 51.74% from a year ago — trailing twelve months through Dec 2025 was 326198000.0 (down 62.96% YoY), and the annual figure for FY2025 was 326198000.0, down 62.96%.
  • Income from Continuing Operations for Q4 2025 was 97044000.0 at Praxis Precision Medicines, down from 78359000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for PRAX hit a ceiling of 25516000.0 in Q3 2023 and a floor of 97044000.0 in Q4 2025.
  • Median Income from Continuing Operations over the past 4 years was 50390000.0 (2022), compared with a mean of 54211062.5.
  • Biggest five-year swings in Income from Continuing Operations: surged 44.67% in 2023 and later crashed 130.01% in 2024.
  • Praxis Precision Medicines' Income from Continuing Operations stood at 41453000.0 in 2022, then skyrocketed by 32.92% to 27806000.0 in 2023, then crashed by 130.01% to 63956000.0 in 2024, then tumbled by 51.74% to 97044000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 97044000.0 (Q4 2025), 78359000.0 (Q3 2025), and 76067000.0 (Q2 2025) per Business Quant data.